Order of the National Green Tribunal in the matter of News Item titled "2 killed in blast at illegal cracker unit in Thanjavur appearing in The Hindu dated 19.05.2025". The application is registered suo-motu on the basis of the news item titled 2 killed in blast at illegal cracker unit …
Onco Therapies Ltd, a wholly-owned subsidiary of Strides Arcolab Ltd, has announced that it has received US FDA approval for Cladribine injection. Cladribine is part of the oncology (cancer) drug portfolio licensed to Pfizer in January 2010 for the US market. The drug comes in 1 mg/ ml packaged in …
Environmental contamination by pharmaceuticals is reaching alarming levels and is set to rise. New partnerships between drug companies, the public-health sector and those who deliver environmental sustainability are urgently needed to tackle the issue. (Correspondence)
Strides Arcolab Ltd. Friday said its unit has received U.S. regulatory approval for a generic version of cancer treating paclitaxel injections, which the Indian company will launch immediately through partner Pfizer Inc. Generic paclitaxel injections have estimated annual U.S. sales of $46 million, the company said in a statement. Strides …
The National Pharmaceuticals Pricing Policy 2011 presently seeks to limit itself to the central objective of promulgating the principles for pricing of Essential Drugs as laid down in the “National List of Essential Medicines ‐ 2011” as declared by the Ministry of Health and Family Welfare, Government of India vide …
Last week just as Swiss pharmaceuticals giant Novartis was set to begin its final arguments in the Supreme Court against the rejection of a patent for its cancer drug Glivec (see ‘Evergreen Novartis’, Down To Earth, September 1-15) there were two swift and stunning developments. A letter was written by …
A report by an expert group on Universal Health Coverage (UHC) has suggested wide-ranging institutional reforms to regulate the public and the private sectors to ensure assured quality and rational pricing of healthcare services. The group, set up by the Planning Commission to develop a blue print and investment plan …
Rajasthan Medical and Health Minister Aimaduddin Ahmed Khan has laid emphasis on expansion of Indian systems of medicine and improving the standard of their drugs to maintain people's faith in these streams for treatment of serious diseases. Addressing a meeting with private drug manufacturers for running a speciality clinic here …
Chinese and Indian drugmakers have taken over much of the global trade in medicines and now manufacture more than 80 per cent of the active ingredients in drugs sold worldwide. But they had never been able to copy the complex and expensive biotech medicines increasingly used to treat cancer, diabetes …
As the UN begins its meeting to devise strategies to tackle NCDs, Indian public health activists say it was a wake-up call for the health authorities in India. Some of them expressed concern that the meeting may be used to push industry agenda.
New Delhi: The scientific community involved in medical research is in jitters as the Animal Welfare Board of India has come up with a draft Animal Welfare Act, 2011, that has listed punishment for not taking proper care of animals used for experiments. These animals may include anything — mouse, …
Global leaders are preparing to meet in New York on September 19 and 20 to chart the way forward to tackle noncommunicable diseases, the number one killer in the world. On the stealth, the pharma and food industries and some rich countries are also at work to weaken the initiative. …
WHILE waste from drug factories continues to be a major concern for the environment, not much attention is paid to pollution that results from household consumption of drugs. Very few models exist to trace the trajectory of drugs and determine their fate. Now scientists from Autonomous University of Barcelona in …
For sheer persistence you have to hand it to Novartis. Ever since its blood cancer drug Glivec was refused a patent in 2006, the Swiss multinational has been fighting India’s patent law, or at least a crucial section of it, with the patent authorities and in the courts. With case …
The Madras High Court has quashed a notification issued by the Centre in February this year in so far as it related to banning of manufacture, sale and distribution of Phenylpropanolamine (PPA). The drug is an ingredient in various formulations used in the treatment of common cold, body pain and …
Madras High Court says the matter was not discussed with concerned parties Paediatric drugs nimesulide and phenylpropanolamine (PPA) will soon be available with chemists after a court order revoked a ban on manufacture and sale of these controversial formulations. Early this year, the health ministry had banned sale of anti-inflammatory …
Over a third of the Indian pharmacies continue to sell to livestock farmers the banned killer drug, diclofenac, responsible for the dramatic fall in vulture population in the country. A study published in the Oryx , a leading international scientific journal of conservation, and reported by BirdLife International, has found …
Pharmaceutical waste is a big, expensive problem. Americans dispose of an estimated $1 billion worth of unused medications annually. Doing so wastes precious health resources, and pollutes the environment too. A study in 2008 found the presence of pharmaceuticals in the water supply of 24 major municipalities nationwide. As legislators …
At AstraZeneca we are proactively addressing the problem of pharmaceuticals entering the environment as a result of our manufacturing discharges (Nature 476, 265; 2011). (Correspondence)
Over the past decade, India has witnessed a phenomenal growth in the clinical trial industry. The projections forecast a double-digit growth over the next decade propelled by enhanced outsourcing by drug developing companies.
